12:00 AM
 | 
Jun 17, 2013
 |  BC Week In Review  |  Company News  |  Deals

Isomerase Therapeutics, NeuroVive deal

NeuroVive partnered with Isomerase to develop and commercialize preclinical cyclophilin inhibitors that NeuroVive acquired from Biotica Technology Ltd. (Cambridge,...

Read the full 91 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >